Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: LRCX

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Markets
  • Options

Lam Research Whale Trades For December 13

By Benzinga Insights
Today, 8:24 AM
Someone with a lot of money to spend has taken a bearish stance on Lam Research (NASDAQ:LRCX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

LRCX

Read More
1 minute read
  • Earnings
  • Intraday Update
  • Markets
  • News

Price Over Earnings Overview: Lam Research

By Benzinga Insights
Today, 8:24 AM
 

LRCX

Read More
2 minute read
  • Markets
  • Options

Lam Research Whale Trades For December 10

By Benzinga Insights
Today, 8:24 AM
A whale with a lot of money to spend has taken a noticeably bearish stance on Lam Research. Looking at options history for Lam Research (NASDAQ:LRCX) we detected 16 strange trades.

LRCX

Read More
2 minute read
  • Intraday Update
  • Markets
  • News

What Does Lam Research’s Debt Look Like?

By Benzinga Insights
Today, 8:24 AM
  Over the past three months, shares of Lam Research (NASDAQ:LRCX) rose by 15.49%. Before we understand the importance of debt, let us look at how much debt Lam Research has.

LRCX

Read More
1 minute read
  • News

‘Introducing Syndion® GP: powering the future of advanced power devices’ -Lam Research

By Benzinga Newsdesk
Today, 8:24 AM
https://blog.lamresearch.com/introducing-syndion-gp-powering-the-future-of-advanced-power-devices/

LRCX

Read More
1 minute read
  • Dividends
  • Earnings
  • News

$100 Invested In This Stock Over The Last 15 Years, Would Be Worth This Much

By Benzinga Insights
Today, 8:24 AM
Lam Research (NASDAQ:LRCX) has outperformed the market over the past 15 years by 10.07% on an annualized basis.

LRCX

Read More
1 minute read
  • Earnings
  • Long Ideas
  • Media
  • News
  • Tech
  • Trading Ideas

Nancy Tengler Shows Interest In These 2 Semiconductor Stocks

By Craig Jones
Today, 8:24 AM
On CNBC’s "Trading Nation," Nancy Tengler of Laffer Tengler Investments discussed chip stocks and congratulated investors who owned Wolfspeed Inc (NYSE: WOLF) after the

LRCX

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Summit Insights Group Downgrades Lam Research to Hold

By Benzinga Newsdesk
Today, 8:24 AM
Summit Insights Group analyst Kinngai Chan downgrades Lam Research (NASDAQ:LRCX) from Buy to Hold.

LRCX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

B. Riley Securities Maintains Buy on Lam Research, Lowers Price Target to $750

By Benzinga Newsdesk
Today, 8:24 AM
B. Riley Securities analyst Craig Ellis maintains Lam Research (NASDAQ:LRCX) with a Buy and lowers the price target from $815 to $750.

LRCX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Morgan Stanley Maintains Overweight on Lam Research, Lowers Price Target to $710

By Benzinga Newsdesk
Today, 8:24 AM
Morgan Stanley analyst Joseph Moore maintains Lam Research (NASDAQ:LRCX) with a Overweight and lowers the price target from $726 to $710.

LRCX

Posts navigation

Previous 1 … 14 15 16 … 18 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service